Crysvita 30mg (Burosumab-Twza Vials) 30mg/ml x 1ml

Crysvita 30mg (Burosumab-Twza) is a prescription injectable solution used for managing certain metabolic bone disorders. This 30mg/ml vial supports targeted therapy with precise dosing. Store between 2-8°C to maintain stability. Ideal for patients requiring FGF23 pathway modulation.

Strength

30mg/ml x 1ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Kyowa Kirin

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Crysvita 30mg (Burosumab-Twza) is used to treat X-linked hypophosphatemia (XLH) in adults and children. It helps manage chronic hypophosphatemia by increasing phosphate levels in the blood. This medication supports bone mineralization and reduces skeletal deformities. It is also indicated for tumor-induced osteomalacia (TIO) in adults when tumors cannot be removed.

Side Effects

Crysvita 30mg may help improve bone strength and reduce pain associated with metabolic bone disorders. Patients often report gradual improvements in mobility and physical function over time. Some may experience injection site reactions like redness or swelling. Regular monitoring is recommended to assess treatment progress.

Precautions & Warnings

Keep Crysvita 30mg refrigerated between 2-8°C and protect from light. Do not freeze or shake vigorously. Discard any unused solution after opening. Patients should inform their healthcare provider about any pre-existing conditions, especially kidney issues. Pregnant or breastfeeding individuals should consult a doctor before use.

Avoid Interactions

Crysvita 30mg may interact with phosphate supplements or vitamin D analogs, requiring careful dose adjustments. Avoid concurrent use of other phosphate-lowering therapies unless directed. Alcohol and certain medications like diuretics may affect phosphate balance. Always disclose all medications to your healthcare provider.

References

Frequently Asked Questions

Crysvita 30mg is used to treat X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO) by increasing phosphate levels.

Store Crysvita 30mg between 2-8°C and protect from light. Do not freeze or shake the vial.

Consult a healthcare provider before using Crysvita 30mg if pregnant or breastfeeding.

Common effects include injection site reactions like redness or swelling. Monitor for changes and report concerns to a doctor.

Yes, Crysvita 30mg is a prescription medication and should only be used under medical supervision.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.